You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 290 No. 2, July 9, 2003 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Correction
 This Article
 •PDF of this Correction
 •Original article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 Report—Correction

JAMA. 2003;290:197.

Incorrect Drug Trade Names: In the Special Communication entitled "The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 Report" published in the May 21, 2003, issue of THE JOURNAL (2003;289:2560-2572), there were incorrect drug trade names in Table 4 and Table 5 . On page 2566, in Table 4 , the trade name "Tevetan" should have read "Teveten" and on page 2567, in Table 5 , the trade name "Aldactone" should have read "Aldactazide." In addition, on page 2565, in column 1, the first full sentence should have read "When BP is more than 20 mm Hg above the systolic BP goal or 10 mm Hg above the diastolic BP goal, consideration should be given to initiating therapy with 2 drugs, either as separate prescriptions or in fixed-dose combinations (Figure)."



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

E/E' ratio is more sensitive than E/A ratio for detection of left ventricular diastolic dysfunction in systemic lupus erythematosus
Lee et al.
Lupus 2008;17:195-201.
ABSTRACT  

Cardiac Rehabilitation and Secondary Prevention of Coronary Heart Disease: An American Heart Association Scientific Statement From the Council on Clinical Cardiology (Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity), in Collaboration With the American Association of Cardiovascular and Pulmonary Rehabilitation
Leon et al.
Circulation 2005;111:369-376.
ABSTRACT | FULL TEXT  

Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women
Mosca et al.
Arterioscler. Thromb. Vasc. Bio. 2004;24:e29-50.
FULL TEXT  

Clinical Management of Metabolic Syndrome: Report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association Conference on Scientific Issues Related to Management
Grundy et al.
Circulation 2004;109:551-556.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.